stavudine has been researched along with Allodynia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bilbrey, JA; Felix, JS; McCurdy, CR; McMahon, LR; Wilkerson, JL | 1 |
| Bathgate, G; Bennett, DLH; Calvo, M; Huang, W; Karu, K; Okuse, K; Olausen, HR; Rice, ASC | 1 |
| Galeotti, N; Ghelardini, C; Sanna, MD | 1 |
| Bansal, Y; Kuhad, A; Marwaha, L; Saroj, P; Singh, R; Sodhi, RK | 1 |
| Kamerman, PR; Mitchell, B; Mitchell, D; Veliotes, D; Weber, J | 1 |
| Dorsey, SG; Leitch, CC; Lessans, S; McGuire, WC; Renn, CL; Rhee, P; Smith, BA; Traub, RJ | 1 |
| Kamerman, PR; Mitchell, D; Weber, J | 1 |
7 other study(ies) available for stavudine and Allodynia
| Article | Year |
|---|---|
Characterization of a mouse neuropathic pain model caused by the highly active antiviral therapy (HAART) Stavudine.
Topics: Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Morphine; Naltrexone; Neuralgia; Stavudine | 2021 |
A clinically relevant rodent model of the HIV antiretroviral drug stavudine induced painful peripheral neuropathy.
Topics: Activating Transcription Factor 3; Animals; Anti-HIV Agents; Brain; Calcitonin Gene-Related Peptide; Disease Models, Animal; Exploratory Behavior; Ganglia, Spinal; Gene Expression Regulation, Viral; HIV Infections; Hyperalgesia; Lectins; Male; Nerve Tissue Proteins; Neuralgia; Neuropeptide Y; Psychomotor Performance; Rats; Rats, Wistar; Reproducibility of Results; Sensory Receptor Cells; Stavudine; Sural Nerve; Time Factors | 2013 |
Blockade of the spinal BDNF-activated JNK pathway prevents the development of antiretroviral-induced neuropathic pain.
Topics: Animals; Anthracenes; Anti-Retroviral Agents; Brain-Derived Neurotrophic Factor; Caspase 3; Cold Temperature; Hyperalgesia; Male; MAP Kinase Kinase 4; MAP Kinase Signaling System; Mice; Models, Animal; Neuralgia; Protein Kinase Inhibitors; Random Allocation; Spinal Cord; Stavudine; Touch; Zalcitabine | 2016 |
Niflumic acid, a TRPV1 channel modulator, ameliorates stavudine-induced neuropathic pain.
Topics: Analgesics; Animals; Biomarkers; Dose-Response Relationship, Drug; Hyperalgesia; Interleukin-1beta; Lipid Peroxidation; Male; Motor Activity; Neural Conduction; Neuralgia; Niflumic Acid; Nitrites; Oxidative Stress; Rats, Sprague-Dawley; Stavudine; TRPV Cation Channels; Tumor Necrosis Factor-alpha | 2016 |
Hyperalgesia induced by oral stavudine administration to rats does not depend on spinal neuronal cell death, or on spinal or systemic inflammatory cytokine secretion, or metabolic dysregulation.
Topics: Adiponectin; Administration, Oral; Animals; Apoptosis; Cytokines; Female; Hyperalgesia; Inflammation; Lactic Acid; Neurons; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Inhibitors; Spinal Cord; Stavudine | 2009 |
Brain-derived neurotrophic factor modulates antiretroviral-induced mechanical allodynia in the mouse.
Topics: Animals; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Hyperalgesia; Injections, Spinal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peripheral Nervous System Diseases; Posterior Horn Cells; Receptor, trkB; Recombinant Fusion Proteins; Reverse Transcriptase Inhibitors; Stavudine | 2011 |
Oral administration of stavudine induces hyperalgesia without affecting activity in rats.
Topics: Administration, Oral; Analysis of Variance; Animals; Antimetabolites; Behavior, Animal; Body Mass Index; Body Weight; Eating; Female; Hyperalgesia; Motor Activity; Pain Measurement; Physical Stimulation; Rats; Rats, Sprague-Dawley; Reaction Time; Running; Stavudine | 2007 |